arsenic has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohle, DS; Colombo, M; Diaz, Z; Mann, KK; Miller, WH; Schipper, HM; Smith, KN; Su, H | 1 |
| Bismar, TA; Diaz, Z; Laurenzana, A; Mann, KK; Miller, WH; Schipper, HM | 1 |
2 other study(ies) available for arsenic and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines.
Topics: Annexin A5; Antioxidants; Apoptosis; Arsenic; Cell Division; Cell Line, Tumor; Chromans; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Promyelocytic, Acute; Membrane Proteins; Oxidative Stress | 2005 |
Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Chromans; Cytochromes c; Drug Synergism; Humans; Liver; Lymphoma; Membrane Potential, Mitochondrial; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Oxides | 2007 |